According to Rob Hillman, CEO of ActivX Biosciences, the ability — and technology — to find low-abundance proteins “is an art.”

Enter the artist, David Campbell, in the new position of vice president of chemistry. Campbell, 42, began his career in biotech but until 1999 couldn’t find the link between the new biology and his own specialty, chemistry. Ruedi Aebersold’s paper on ICAT technology changed Campbell’s outlook. “For the first time, I saw a role for chemistry in proteomics,” he recalls.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.